MRIGlobal

Through the COVID-19 pandemic and since, research performed in our CAP/CLIA laboratories has assisted customers in moving diagnostic devices through regulatory approvals. Our expertise and instrumentation support the process at a world-class level. Come see us at #AMPATH24, at booth #600, schedule time with Dominie Garcia, Robert Krumsick, or Susan Houser MBA, PMP, CTA to learn more about our facilities and team, or read more about our expertise here: https://lnkd.in/gauK4jtd

Beyond issues like the COVID-19 pandemic, there are countless other looming challenges that could potentially disrupt the continuity of your day-to-day operations. Read more about these challenges and how to mitigate their impact on your operation.

Biosafety is most often applied to work in the laboratory or to research-related activities, but should also have a role in risk mitigation outside the lab. Read more on the blog --->

MRIGlobal performed analytical and flex studies on Cepheid's new Hepatitis C virus diagnostic test with support from The National Institutes of Health's Rapid Acceleration of Diagnostics (RADx®) Independent Test Assessment Program (ITAP), accelerating it through FDA's marketing authorization process. Read more on the blog --->

Effective contingency planning requires that the laboratory and its staff be included, ensuring that the team can maintain operations. Read more on the blog --->

Next week, join our Evan Durnal at CBRNe World's CBRNe Convergence, where he will be speaking on "Decontamination Efficacy Validations for Clandestine Sites." #CBRNe

Heading to PharmSci 360 next week? Our team specializes in management, storage and distribution of high-purity reference standards, markers, and isolated impurities to support analytical method development, validation, formulation and other developmental work. MRIGlobal’s highly experienced team can support GxP compliant analytical characterization and re-certification, as well as synthesis of new standards and analytical markers when supply runs low. Schedule time with our Sr. Director, Aaron Heiss, Ph.D. at aheiss@mriglobal.org to learn more about our facilities, team, and expertise.

We were saddened to learn of the recent passing of former MRIGlobal Chairman of the Board and Life Trustee, Donald J. Hall. His support for our work and the growth of Kansas City's businesses, philanthropy, and culture were extraordinary. Rarely has someone been such a uniformly positive influence on a community for so long. His work, and that of his late wife Adele, leaves a lasting legacy that will long benefit our community. 

As new diseases like SARS-CoV-2 and Mpox emerge, clients call on MRIGlobal to partner in supporting FDA approvals for their diagnostics. Come see us at #AMPATH24 next month at booth #600, schedule time with Dominie Garcia, Robert Krumsick, or Susan Houser MBA, PMP, CTA to learn more about our facilities and team, or read more about our expertise here: https://lnkd.in/gauK4jtd

The bolded “MRI” in our wordmark is reminiscent of the institute’s founding as Midwest Research Institute, while the word “Global” emphasizes our vision of placing these solutions within everyone’s reach. Read more on the blog ---> https://lnkd.in/gciTzuWC